Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
QuintilesIMS
AstraZeneca
Harvard Business School
Teva
Cerilliant
Accenture
Fuji
Novartis
Cantor Fitzgerald

Generated: December 11, 2017

DrugPatentWatch Database Preview

Drug Master Files for: tofacitinib

« Back to Dashboard


DMF No. Status Type Submission Date Holder Subject
29002AII3/11/2015GLENMARK PHARMACEUTICALS LTDTOFACITINIB CITRATE
27721AII11/30/2013MSN LABORATORIES PRIVATE LTDTOFACITINIB CITRATE [ROUTE CODE - TT]
30531AII6/4/2016CADILA HEALTHCARE LTDTOFACITINIB CITRATE
30554AII5/19/2016SINTENOVO SA DE CVTOFACITINIB CITRATE
30578AII6/13/2016QILU TIANHE PHARMACEUTICAL CO LTDTOFACITINIB CITRATE (NON-STERILE API)
30686AII6/22/2016OLON SPATOFACITINIB CITRATE
30617AII8/2/2016SUN PHARMACEUTICAL INDUSTRIES LTDTOFACITINIB CITRATE
30621AII8/3/2016MICRO LABS LTDTOFACITINIB CITRATE
30654AII7/5/2016UNICHEM LABORATORIES LTDTOFACITINIB CITRATE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Mallinckrodt
Federal Trade Commission
Boehringer Ingelheim
Citi
Harvard Business School
Medtronic
Express Scripts
Cipla
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot